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Dual X-ray absorptiometry of the lumbar spine but not the hip:
Any problems with a Swiss policy?
Abstract
Introduction: Osteoporosis is a growing healthcare problem in societies with aging populations and
DXA is increasingly important to evaluate patients at risk and measure effects of osteoporosis treatment.
In Switzerland, as in most Western countries, growing expense of public healthcare forces public
authorities to take cost-saving action. The restriction of reimbursement for DXA measurement of the hip
might impact negatively on patient care.
Methods: We retrospectively evaluated data of 770 patients (59.3 ± 14.6 years, 14 - 91 years; 91 male
and 679 female) and analyzed the proportion of patients with low bone mass as based on DXA
measurements of a hip/spine combination of measurements or a single measurement of the lumbar
spine.
Results: There was a significant number of discordant measurements of T-score values between lumbar
spine and total hip compared to concordant measurement results in all patients (p<0.0001) and in
postmenopausal women (p<0.0001).
Conclusion: DXA measurement of the lumbar spine only may miss correct diagnosis of osteopenia or
osteoporosis in a significant number of patients. Therefore, it is important to examine both lumbar spine
and hip in order to maintain patient care standards.
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Abstract: Introduction: Osteoporosis is a growing healthcare problem in societies with aging populations and DXA is 
increasingly important to evaluate patients at risk and measure effects of osteoporosis treatment. In Switzerland, as in 
most Western countries, growing expense of public healthcare forces public authorities to take cost-saving action. The 
restriction of reimbursement for DXA measurement of the hip might impact negatively on patient care.  
Methods: We retrospectively evaluated data of 770 patients (59.3 ± 14.6 years, 14 - 91 years; 91 male and 679 female) 
and analyzed the proportion of patients with low bone mass as based on DXA measurements of a hip/spine combination 
of measurements or a single measurement of the lumbar spine. 
Results: There was a significant number of discordant measurements of T-score values between lumbar spine and total hip 
compared to concordant measurement results in all patients (p<0.0001) and in postmenopausal women (p<0.0001). 
Conclusion: DXA measurement of the lumbar spine only may miss correct diagnosis of osteopenia or osteoporosis in a 
significant number of patients. Therefore, it is important to examine both lumbar spine and hip in order to maintain patient 
care standards. 
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INTRODUCTION 
 The measurement of bone mineral density (BMD) using 
Dual Energy X-ray Absorptiometry (DXA) is a standard 
method to diagnose osteoporosis and assess fracture risk [1-
4]. Since osteoporosis is a growing healthcare problem in 
societies with aging populations, DXA is increasingly impor-
tant to evaluate patients at risk and measure effects of osteo-
porosis treatment. However, DXA is not suitable for 
screening large populations, because it is relatively expen-
sive and has limited availability in many countries. In 
Switzerland, as in most Western countries, growing expense 
of public healthcare forces public authorities to take cost-
saving action.  
 The incidence of hospitalization after fracture of lower 
extremity and axial skeleton increases exponentially after the 
age of 65. Fractures of the forearm, vertebral bodies and hip 
are responsible for 79.3%/74.1% (female/male) of hospita-
lized patients with osteoporotic fractures in Switzerland [5]. 
 To date, the Swiss Federal Social Insurance Office regu-
lates that bone densitometry is to be reimbursed by insurance 
companies for measurement at the lumbar spine additional 
measurement sites may not be separately reimbursed [6]. In 
contrast, several national and international societies, such as 
The International Osteoporosis Foundation, The American 
Society for Bone and Mineral Research, and The American  
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Association of Clinical Endocrinologists, recommend mea-
surement at the spine and hip. This is in accordance to the 
official position of the International Society for Clinical 
Densitometry (ISCD). The correct measurement implies 
DXA acquisition at more than one site using lowest T-score 
value as obtained from one of these measurement sites to 
diagnose low bone mass (i.e. osteopenia/osteoporosis). The 
inverse conclusion is that DXA-based diagnosis of osteo-
penia/osteoporosis is not sufficiently reliable if measuring 
only one site.  
 Recently, it was suggested that the combination of DXA 
results obtained from the lumbar spine and femoral neck 
with selection of the lowest T-Score value does not improve 
ability for fracture prediction compared with either site alone 
as previously predicted [7]. Kanis et al. hypothesized that 
lack of additive value of measuring multiple sites for diag-
nosis of osteoporosis, as found in their retrospective evalua-
tion of more than 19000 patients from six prospectively 
studied population-based cohorts, may relate to progressive 
osteoarthritis with age in the lumbar spine. This implies that 
hip measurement is more meaningful for assessment of 
fracture risk. In contrast, the lumbar spine is thought to be 
valuable for treatment monitoring. However, results of these 
authors show that, in their population, BMD measurement of 
the lumbar spine predicted any fracture and any osteoporotic 
fracture as well as measurement of the femoral neck [7]. To 
keep in mind that the predictive power of a single measure-
ment may depend on prevalence of the disease in a given 
population [7]. The IOF recommends diagnostic criteria 
should be confined to DXA at the femoral neck using a 
single-reference base [8].  
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 Based on the assumption that restriction of reimburse-
ment for DXA measurement of the hip might impact 
negatively on patient care, we evaluated the proportion of 
patients with low bone mass as based on DXA measure-
ments of a hip/spine combination of measurements or single 
measurement of the lumbar spine. 
MATERIALS AND METHODS 
Patients  
 All electronic files of patients undergoing DXA of the 
lumbar spine and hip between June and October 2003 at the 
Osteoporosis Center University Hospital Zurich were 
evaluated retrospectively. The evaluation was in accordance 
to ethical guidelines of our institutional review board and use 
of data for this analysis was approved by the local ethics 
committee. 
DXA Measurements 
 All DXA measurements were performed on the supine 
patient at lumbar spine and non-dominant hip with Hologic 
QDR 4500 A and C devices (Hologic Inc., Waltham, MA). 
The two devices were cross-calibrated using a spine phantom 
and daily quality controls were performed by the same two 
experienced technicians during the study period. In 2003 the 
regions of interest (ROI) at the lumbar spine were placed in 
the vertebral body L2 – L4 and in the hip a total ROI with 
additional ROIs in the Ward’s triangle, femoral neck, and 
trochanter. BMD was given as absolute values in g/cm
2
, and 
as Z-score and T-score values. The T-score corresponds to 
the number of standard deviations from the mean of a 
gender-matched reference population of young adults, 
defined as Peak Bone Mass, as provided by the manufac-
turer. In agreement with the ISCD guidelines, osteopenia or 
osteoporosis were defined according to lowest measured T-
score value in either spine or hip. Osteopenia, as defined by 
the WHO classification, corresponds to a T-score value 
between -1.0 and -2.5. Osteoporosis was defined as T-score 
value of -2.5 and lower. Low bone mass is defined as T-
score value ? -1.0 [9]. Measurement of the non-dominant 
forearm is not routinely acquired in our institution since 
diagnosis of osteoporosis is based on lumbar spine and hip 
measurement and 33% radius is considered to be more 
valuable in patients wit hyperparathyroidism and for therapy 
control.  
Data Analysis 
 The quality of all DXA measurements was assessed 
visually and scans from patients with lumbar spine and hip 
measurements were analyzed. All scans with minor quality 
(e.g. due to metal artefacts) and patients undergoing mea-
surement of the non-dominant forearm were excluded. The 
T-score values as measured at the lumbar spine, total hip and 
femoral neck were used for statistical comparisons. It is well 
known that T-score cannot be used universally in all age 
groups and it is primarily reserved to evaluate fracture risk in 
postmenopausal women [10, 11]. We chose to use T-score 
values as cut-offs to generate patient subgroups (in 
postmenopausal women, premenopausal women and males, 
and young patients) to simplify statistical comparison, since 
the purpose of this study was not predicting fracture risk in 
individual patients. The importance of T-score values is only 
given within the clinical context of an individual patient and 
according to recommendations for DXA testing for the 
corresponding age group and gender. Additionally, analysis 
of frequency distribution was performed in postmenopausal 
women, where T-score values can be directly linked to 
fracture risk. 
Statistics 
 Mean value and standard deviation is given for normally 
distributed values. The frequencies of T-score > -1.0 and T-
score ? -1.0 at lumbar spine and hip or femoral neck, 
respectively, were calculated for all patients. Additionally, 
frequency of T-score > -1.0 in postmenopausal women was 
compared to T-score ? -1.0 and ? -2.5. Sign test served to 
compare differences in the number of concordant and 
discordant findings between lumbar spine and total hip or 
femoral neck measurement, for all patients and the subgroup 
of postmenopausal women, respectively. McNemar test 
served to compare frequencies of the two possibilities of 
discordant findings, i.e. normal T-score values at lumbar 
spine with low T-score values at total hip or femoral neck 
and low T-score values at lumbar spine with normal T-score 
values at total hip or femoral neck. Bonferroni correction 
was done for multiple measurements and p-value of less than 
0.005 was considered significant.  
RESULTS 
Patients 
 The data of 770 patients (59.3 ± 14.6 years, 14 - 91 years; 
91 male and 679 female) were analyzed. Patients were sent 
for various clinical indications, such as suspicion of osteopo-
rosis-related fracture, rheumatologic disease, endocrine 
disorders, long-term steroid medication, and anorexia 
nervosa. There was also a group of young patients not likely 
to have reached peak bone mass (age 14 - 28 years, n=43). 
Frequency Distribution and Comparisons  
At the lumbar spine, 549/770 patients (71.3%) had low bone 
mass, at the hip 419 patients (total hip region; 54.4%) and 
546 patients (femoral neck region; 70.9%), respectively 
(Table 1 and Table 2).  
Table 1. Number of Patients with T-Score Values Indicating 
normal Bone Mass, Osteopenia and Osteoporosis for 
the Three Different Regions of Interest. Number of 
patients in subgroups with T-score values in the normal 
range, T-score values ? -1.0 and > -2.5, and T-score 
values ? -2.5 as obtained by DXA at the different 
measurement sites. All 770 patients of both gender and 
all age groups are included 
 
 
T-score value 
> -1.0 
T-score value 
? -1.0 and > -2.5 
T-score value  
? -2.5 
Lumbar Spine 221 334 215 
Femoral Neck 224 417 129 
Total Hip 351 352 67 
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Table 2. Number of Patients with T-Score Values Indicating 
Normal Bone Mass, Osteopenia and Osteoporosis 
Splitted for the Different Regions of Interest. 
Frequency distribution in 770 male and female patients 
of all age groups as obtained by DXA of the lumbar 
spine, total hip, and femoral neck splitted for T-score 
values in the normal range, T-score values ? -1.0 and > 
-2.5, and T-score values ? -2.5. In the group of young 
patients with nutritional problems (n=43) the lumbar 
spine measurement always corresponded to a T-score 
value ?1.0 
 
 
Lumbar Spine  
T-score value > -1.0 
(n=221) 
Lumbar Spine  
T-score value 
? -1.0 and > -2.5 
(n=334) 
Lumbar Spine 
T-score value 
? -2.5 
(n=215) 
Total Hip 
T-score value 
> -1.0 
179 140 32 
Total Hip 
T-score value 
? -1.0 and > -
2.5 
40 183 129 
Total Hip 
T-score value 
? -2.5 
2 11 54 
    
Femoral Neck 
T-score value 
> -1.0 
142 70 12 
Femoral Neck 
T-score value 
? -1.0 and > -
2.5 
74 227 116 
Femoral Neck 
T-score value 
? -2.5 
5 37 87 
 
Frequency Distribution in all Patients (n=770) 
 In 23% of patients lumbar spine and total hip T-score 
value were in normal range. In 49% of patients, both 
measurements indicated low bone mass and in 28% a 
discordant finding was present (22% lumbar spine T-score ? 
-1.0 and normal T-score at the total hip; 6% normal lumbar 
spine T-score and the total hip T-score ? -1.0). There was 
significant number of discordant findings compared to con-
cordant measurement results (p<0.0001). The combination of 
low T-score value at lumbar spine and normal T-score value 
at total hip was more common than the reversed combination 
(p<0.001).  
 In 18% of patients, lumbar spine and femoral neck value 
indicated a T-score value in normal range and in 61% both 
measurements a low bone mass. In 21% a discordant finding 
was present (11% lumbar spine T-score ? -1.0 and normal 
femoral neck; 10% normal lumbar spine and femoral neck T-
score ? -1.0). There was a significant number of discordant 
findings compared with concordant measurement results 
(p<0.0001). There was no significant difference between 
frequencies of combination of low T-score value at lumbar 
spine with normal T-score value at femoral neck and the 
reversed combination (p=.0875). 
Frequency Distribution in Postmenopausal Women 
 In 555 postmenopausal women the distribution for the 
relationship between lumbar spine and total hip measure-
ments was: in 22%, lumbar spine T-score value and total hip 
T-score value were normal and in 51% both measurements 
indicated low bone mass. In 27% the finding was discordant 
(21% low bone mass at lumbar spine with normal T-score at 
the total hip, in 6% lumbar spine T-score normal and low 
bone mass at the total hip). There were significant number of 
discordant findings compared with concordant measurement 
results (p<0.0001). The combination of low T-score value at 
lumbar spine with normal total hip T-score value was 
significantly more common than the reversed combination 
(p<0.0001).  
 In 28% of patients, lumbar spine T-score and femoral 
neck T-score values indicated normal bone mass and in 17% 
both measurements indicated low bone mass. In 55% a 
discordant finding was present (54% low bone mass at 
lumbar spine and normal T-score value at femoral neck; in 
0.5% lumbar spine T-score value was normal and the femo-
ral neck showed low bone mass). There were significantly 
more discordant findings than concordant measurement 
results (p<0.0001). In most patients with discordant 
measurement results, lumbar spine T-score value was low 
and femoral neck value was in normal range (p<0.0001).  
 Omitting the hip as a measurement site in 555 postmeno-
pausal women impacts on final DXA-based diagnosis as 
follows: in case of a normal BMD measurement result at 
lumbar spine (n=157), 32 postmenopausal women (20%) 
would have been missed with low bone mass at total hip (2 
osteoporosis, 1%) and 57 patients (36%) with low bone mass 
at femoral neck (3 osteoporosis, 2%).  
DISCUSSION 
 The data of this retrospective evaluation suggest mea-
surement of the lumbar spine only may miss correct diag-
nosis of osteopenia or osteoporosis in a significant number 
of patients and in up to 37% of postmenopausal women. 
Therefore, we feel it is important to examine both lumbar 
spine and hip as suggested by several international societies, 
in order to maintain patient-care standards. 
 Switzerland has approximately 7.6 million inhabitants. In 
2008 1.4 million women and 1.2 million men were aged 50 
and older. Based on previous reports, about 1 in 3 women 
and 1 in 5 men over 50 will experience osteoporotic fractures 
[12-14]. Identifying and treating patients at risk of fracture 
can help reduce long-term costs. It has been shown that 
treatment of established osteoporosis is cost-effective 
irrespective of age, as it reduces risk of vertebral and 
nonvertebral fractures [15, 16]. In a recent Swiss study, cost-
effectiveness was shown in osteoporosis treatment in 
postmenopausal women aged 65 and older undergoing DXA 
testing [17]. Furthermore, recent data suggest incidence of 
osteoporotic fractures can be reduced in aging populations 
when patients are correctly diagnosed and treated [18]. 
However, it is not possible to prove with our data that 
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improved diagnostic accuracy would also translate into 
improved treatment strategies and consequently in a reduced 
fracture rate. In a recent study it has been shown that in 
Switzerland – one of the countries with the highest risk for 
osteoporotic fractures – the 10 year risk of a major osteo-
porotic fracture can rise up to 24% in women depending on 
clinical risk factors and age [19]. Furthermore, in patients 
with similar clinical risk profile the risk increases when bone 
mass decreases. This underlines a role of DXA for BMD 
measurement to enhance risk assessment. In Switzerland, the 
cost of treatment will be paid by insurance companies in 
patients with proven osteoporosis. DXA measurement is one 
possibility to verify osteoporosis. Therefore, the decision of 
the Swiss Federal Social Insurance Office to commit 
insurance companies to only reimburse measurement at 
lumbar spine may reduce test efficiency and diagnostic 
power of DXA. In the light of possible future costs due to 
osteoporosis, the attempt to reduce health expenses by 
limiting the cost of DXA may be of limited use. However, it 
has been shown that combining results of DXA measurement 
of the lumbar spine and femoral neck does not increase 
predictive ability for osteoporotic fracture compared with 
either site alone and that the use of a femoral neck region 
alone is sufficient [7]. The International Osteoporosis Foun-
dation recommends that diagnostic criteria should be 
confined to the femoral neck as a single measuring site using 
a single reference base [8]. In contrast, in patients under-
going treatment a lumbar spine measurement may be of 
more value for monitoring since the spine is considered to be 
the most responsive site to pharmacologic intervention [7]. It 
is for these reasons that we feel both measurement sites 
should be included on DXA testing. 
 In order to convince health insurance companies as 
payers to also fund the second part of DXA, the gain has to 
be demonstrated in terms of reduced fracture rate leading to 
fewer treatments and finally reduced costs in patients at the 
long term. This in turn could be addressed in a prospective 
study assessing the outcome of patients undergoing measure-
ment of one or two sites and monitoring treatment decisions 
based on DXA measurement. Such study would raise ethical 
questions. Since the correct assessment of bone density 
(according to ISCD standards) involves the measurement of 
two measuring sites the examiner is forced to perform DXA 
according to this standard. Another problem is legal 
implications for the examiner. From the juristic point of view 
it is not justifiable to ask the patient to pay for one of the two 
measurements, since this would imply shortchanging the 
patient in his affliction. Self-pay by patients to obtain 
additional testing would not be allowed even if a patient 
would desire to pay for the second measurement.  
 Results of DXA are only part of patient assessment and 
clinical estimation of risk for fractures with risk scores 
including age, sex, previous and present height, previous 
fracture, family history, medications, lifestyle and dietary 
habits, and medical history are important factors. Decision 
on treatment is based on an overall impression in an 
individual patient. However, it has recently been shown that 
results of DXA testing can change estimation of risk for 
fractures as based on clinical information and that such 
change can be observed already for patients with BMD 
values indicating osteopenia [19]. 
 We feel that this work is a further preliminary step in 
addressing the problem of measuring decreased bone density 
in at risk populations and the possible impact of DXA on 
treatment decisions. Additional investigations should assess 
how DXA results would influence treatment decisions and 
how this would reduce the cost of care. 
 DXA measurement of the lumbar spine only may miss 
correct diagnosis of osteopenia or osteoporosis in a signi-
ficant proportion of patients. Therefore, it is important to 
examine both lumbar spine and hip, as suggested by several 
international societies, in order to maintain patient care 
standards. Reduction of refunds for DXA-scanning as a tool 
to save expenses for public health care might have negative 
effects on the population.  
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